Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03ILU
|
|||
| Former ID |
DNC001605
|
|||
| Drug Name |
D17.4
|
|||
| Synonyms |
26482-53-1; 2-(1-adamantyl)ethanamine; 2-(adamantan-1-yl)ethanamine; 1-C-Ethylaminoadamantane; Tricyclo[3.3.1.13,7]decane-1-ethanamine; 1-Adamantanethylamine; 1-adamantaneethanamine; 2-Adamantan-1-yl-ethylamine; 2-adamantanylethylamine; Tricyclo(3.3.1.13,7)decane-1-ethanamine; PubChem21555; Enamine_005504; D-174; 2-(1-adamantyl)ethylamine; AC1L20RI; 2-(2-amino)ethyladamantane; Oprea1_362282; 2-(Adamant-1-yl)ethylamine; SCHEMBL973650; CHEMBL341013; Mrz-2/174; CTK1A4494; DTXSID50181075; MolPort-002-464-537
Click to Show/Hide
|
|||
| Drug Type |
Aptamer
|
|||
| Indication | Myasthenia gravis [ICD-11: 8C6Y; ICD-10: G70.0; ICD-9: 358] | Investigative | [1] | |
| PubChem Substance ID |
3722278, 5610164, 7735239, 8189176, 11347735, 15042023, 24304211, 25691003, 43121151, 47676258, 57315054, 57567406, 57641760, 78776794, 90408885, 92250088, 93620709, 103362427, 103958140, 104330507, 104670483, 118184144, 124594222, 125340213, 129261406, 131493000, 132521459, 135023332, 135565000, 137065293, 143393349, 143492614, 152235679, 160998549, 162499053, 163585551, 164769547, 172824524, 184642600, 186014954, 223352806, 223797140, 227231510, 241046446, 251900284
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Immunoglobulin E (IgE) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Therapeutic applications of aptamers. Expert Opin Investig Drugs. 2008 Jan;17(1):43-60. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.